Similar observations were previously noted in the liver where knockout of Pacs-2 in mice maintained on a control diet did not result in the change of whole-body adiposity, hepatic steatosis and insulin resistance (Krzysiak et al. 2018). This evidence concerns the gene PACS2 and fatty liver disease.